Vote Scores

Home / Companies / Avidity Biosciences, Inc. / 13 Jun 2024

Meeting · year to 30 June 2024251 filers reporting

Avidity Biosciences, Inc.: meeting of 13 Jun 2024

Votes reported on Form N-PX, item by item

251 Form N-PX filers reported votes at the Avidity Biosciences, Inc. meeting of 13 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 51.1% of reported votes for; 76 filers withheld from or voted against at least one nominee.

619 vote records from 107 filers. 41 of the 106 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

61.7% for0.0% against38.3% other38.7% against management107 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

390 vote records from 249 filers. 31 of the 239 filers that marked the item either way voted against management. 10 filers reported this item without a management mark.

84.3% for11.6% against4.0% other13.0% against management249 filers99.0% for0.9% against0.1% other0.9% against management88,810,955 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

207 vote records from 107 filers. 0 of the 106 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

100.0% for0.0% against0.0% against management107 filers100.0% for0.0% against0.0% against management32,573,277 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesAbstain or withhold *ForFor
FidelityForForFor
DimensionalAbstain or withhold *ForFor
State Street and SPDRForForFor
American CenturyAbstain or withhold *Against *For
InvescoForAgainst *For
EquitableAbstain or withhold *ForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsAbstain or withhold *ForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *Against *For
J.P. MorganForForFor
Goldman SachsAbstain or withhold *ForFor
PGIM and PrudentialForForFor
Jackson National fundsAbstain or withhold *ForFor
Northern Trust and FlexSharesNo reportForNo report
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaForForFor
NationwideAbstain or withhold *Against *For
Victory CapitalAbstain or withhold *ForFor
Brighthouse FundsForForFor
Guggenheim and RydexAbstain or withhold *ForFor
Columbia ThreadneedleNo reportAgainst *No report
BNY MellonNo reportForNo report
PrincipalAbstain or withhold *ForFor
Pacific Life fundsAbstain or withhold *ForFor
Global XForForFor
TransamericaForForFor
Federated HermesNo reportForNo report
AllianceBernsteinNo reportForNo report
Hartford FundsForForFor
DWSAbstain or withhold *ForFor
MassMutualForForFor
Harbor FundsForForFor
Janus HendersonNo reportForNo report
Neuberger BermanNo reportForNo report
BairdNo reportForNo report
Artisan PartnersForForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Avidity Biosciences, Inc. meeting?

251 Form N-PX filers reported votes at the meeting of 13 Jun 2024. On say-on-pay, 31 of 239 voted against management (13.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Avidity Biosciences, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Avidity Biosciences, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Avidity Biosciences, Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.